- Open Access
Apoptosis of non-parasitized red blood cells in malaria: a putative mechanism involved in the pathogenesis of anaemia
© Totino et al; licensee BioMed Central Ltd. 2010
- Received: 30 July 2010
- Accepted: 2 December 2010
- Published: 2 December 2010
Severe anaemia is a common complication of Plasmodium falciparum malaria in hyperendemic regions. Premature elimination of non-parasitized red blood cells (nRBC) has been considered as one mechanism involved in the genesis of severe malaria anaemia. It has been reported that apoptosis can occur in RBC and, consequently, this cell death process could contribute to anaemia. This study was performed to evaluate the susceptibility of nRBC to apoptosis in a malaria anaemia murine model.
Balb/c mice were intraperitonially inoculated with 1 × 106P. yoelii 17XL parasitized RBC (pRBC) and, then, parasitaemia and anaemia were monitored. Apoptosis in both pRBC and nRBC was assessed during early and late phases of infection by flow cytometry using Syto 16 and annexin V-PE double staining and forward scatter measurement.
As expected, experimental infection of Balb/c mice with Plasmodium yoelii 17XL parasites was characterized by progressive increase of parasitaemia and acute anaemia, leading to death. Flow cytometry analysis showed that a number of pRBC was in the apoptotic process. It was noteworthy that the increase of nRBC apoptosis levels occurred in the late phase of infection, when anaemia degree was notably accentuated, while no significant alteration was observed in the early phase.
The increased levels of nRBC apoptosis herein firstly reported, in malaria infection could represent a putative mechanism worsening the severity of malarial anaemia.
- Malaria Infection
- Cerebral Malaria
- Placental Malaria
- Plasmodium Falciparum Malaria
Malaria remains the tropical disease of major prevalence in the world, representing great problem of public health with approximately 250 million cases and 900 thousand deaths annually . From all malaria human parasites, Plasmodium falciparum is the most prevalent and the most frequent parasite species responsible for the severe and lethal forms of the disease. Complications associated to P. falciparum infection include severe anaemia, which affects mainly children and pregnant women living in malaria hyperendemic regions [2, 3].
The immunological processes involved in malaria anaemia cannot be implicated as the sole cause of erythrophagocytosis during malaria . It is well known that, together to mechanical rupture of parasitized red blood cells (pRBC) by the parasite and suppression of erythropoiesis, the premature phagocytosis of non-parasitized RBCs (nRBC) is also a mechanism implicated in the development of severe malaria anaemia [5, 6].
Apoptosis - a physiological process of programmed cell death related to nucleated cells - can also occur in RBC as a result of intracellular influx of Ca2+, which leads to cell shrinkage, membrane blebbing, phosphatidylserine exposure and protease activation . Although apoptosis is an essential phenomenon for cell populations regulation it was also engaged in elimination of damaged, infected and mutated cells as well as in the genesis of many disorders [8, 9]. Enhanced levels of RBC apoptosis have been observed in clinical disorders in which anaemia is a common feature, such as iron and G6PD deficiency, renal insufficiency, thalassaemia, sickle-cell disease and sepsis  and in malaria infection apoptosis has been associated to cerebral malaria, thrombocytopenia and lymphocytopaenia [10–12]. The apoptosis of parasitized RBC does exists and it is also possible that the same phenomenon could concern normal RBC and RBC apoptosis could, therefore, contribute to the genesis of malaria anaemia. In this light, the present study was carried out to evaluate the susceptibility of nRBC to apoptosis in a murine model of malaria anaemia.
The lethal experimental infection of Balb/c mice with Plasmodium yoelii 17XL parasites was used as a malaria anaemia model. Where indicated, non-infected, age-matched mice were used as control. All animal experimentation was approved by the Ethics Committee on the Use of Animals of the Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.
For infection, female Balb/c mice aged 6-8 weeks, provided by the Centre for Laboratory Animals Breeding of the Fiocruz, were intraperitoneally inoculated with 1 × 106P. yoelii 17XL-pRBC in 0.2 mL phosphate buffered saline (PBS). During infection, parasitaemia and anaemia degree were routinely monitored through mice tail blood samples. Parasitaemia was determined by counting the number of pRBC in a total count of 1000 RBC in thin blood smears stained by the Romanowski's method (Panótico Rápido, Laborclin®, Pinhais, PR, Brazil). Anaemia was evaluated by counting the number of RBC/mm3 of blood. Briefly, 2 μL of blood were suspended in 0.5 mL heparinized PBS, diluted 1:10 in the same buffer and, then, the number of RBC determined in a haemocytometer.
Apoptosis was identified in the early (day 4) and late (days 6-7) phases of P. yoelii infection through the detection of phosphatidylserine exposure (PS) at the cell surface and cell shrinkage . For this propose, it was used Syto 16 and annexin V-PE double staining that identify pRBC and PS exposure, respectively. Briefly, RBC were isolated from mice tail heparinized blood by centrifugation at 350 × g for 10 min at room temperature, washed twice with PBS and, then, incubated at 37°C for 40 min at a density of 1 × 105 cells/400 μL in PBS containing 100 nM Syto 16 (Invitrogen). After incubation, staining buffer was discarded and the RBC were stained with 5 μL annexin V (BD Pharmingen) for 15 min at room temperature in 100 μL annexin-binding buffer (BD Pharmingen) containing 100 nM Syto 16. Finally, cells were five times diluted in annexin-binding buffer containing Syto 16 and both forward scatter and fluorescence emission were assessed using a flow cytometer (FACScalibur, Becton Dickinson)
In addition to ex-vivo analysis, apoptosis was also measured after incubation of RBC for 24 h at 37°C at a haematocrit of 0.5% in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO4, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), 5 glucose, and 1 CaCl2 (pH 7.4).
Statistical analyses were performed using t student test in GraphPad Prism 5.0 software (San Diego, CA, USA); a p-value < 0.05 was considered significant.
Data from experimental rodent malaria infection, widely used as malaria models, have reinforced premature destruction of nRBC as a relevant process of malaria anaemia [13, 14]. Thus, to investigate the involvement of nRBC apoptosis in malaria anaemia a P. yoelii 17XL malaria murine model was used in the present report.
The apoptotic process in pRBC has been described as a result of intraerythrocytic plasmodia development. During schizogony, malaria parasites activate non-selective cation channel in host RBC membrane, allowing entry of Ca2+ and Na+ necessary for its intracellular growth . Sequentially, intracellular Ca2+ influx leads to activation of phospholipid scramblase and Ca2+-sensitive K+ channels responsibles to PS exposure at outer membrane leaflet and cell shrinkage, respectively . If one take in mind that apoptotic cells are quickly recognized and removed by phagocytes , apoptosis could act controlling parasite proliferation and even confer partial protection in sickle-cell trait carriers through accelerated clearance of ring-stage pRBC apoptosis .
However, if the augmented elimination of nRBC (for each pRBC, nine nRBC were removed) in both human and experimental malaria [13, 24, 25] could be due, at least in part, by erythrocytic apoptosis, PS exposure could also adversely promote elimination of nRBC, contributing also to malaria anaemia pathogenesis. This hypothesis could be supported by the report that deficiency of PS receptor operating in phagocytosis (i.e., CD36) can confer protection against malaria anaemia in children infected with P. falciparum.
Since nRBC apoptosis was increased during only the late phase of malaria infection, one may wonder which factors could be implicated to its induction? Notably, different types of RBC apoptosis-inducer, such as anti-RBC antibodies, oxidative stress and parasite antigens, are associated to malaria infection . Indeed, anti-erythrocyte auto-antibodies and nitric oxide production are increased during plasmodia infection and they can be associated to anaemia severity [14, 27, 28]. Soluble factors from P. falciparum-pRBC are also capable of inducing apoptosis in endothelial and neuroglia cells  and bystander nRBC in P. falciparum in vitro culture undergo apoptotic process . Moreover, defective production of erythropoietin - a RBC apoptosis inhibitor  - has been also associated with acute anaemia in malaria . Thus, both host immune and parasite-derived factors, could be implicated to nRBC apoptosis during severe malaria anaemia state.
Finally, since ex vivo pRBC and nRBC are capable of exposuring PS and these cells were not significantly sequestrated at the present study, it is presumable that the simple presence of PS is not enough for in vivo endothelium adhesion, as previously suggested in in vitro-measured adhesiveness studies with both pRBC and nRBC [18, 33, 34]. Further studies on in vivo adherence capacity of apoptotic RBC on endothelium are necessary to clarify the role of PS, besides P. falciparum erythrocyte membrane protein 1 (PfEMP1), in cerebral and placental malaria pathogenesis. Intra-vital microscopy studies could help for clarifying these questions.
The present report showed for the first time that malaria infection increase the levels of nRBC apoptosis, a process that could represent a putative mechanism worsening the severity of malaria anaemia. Attempts to decipher immune and parasitic factors related to RBC apoptosis during the course of malaria infection are currently underway on rodent and human malaria.
This work was financially supported by Instituto Oswaldo Cruz-Fiocruz and by Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (Faperj).
- World Health Organization: World Malaria Report. 2008, Geneva: WHOGoogle Scholar
- Menendez C, Fleming AF, Alonso PL: Malaria-related anaemia. Parasitol Today. 2000, 16: 469-476. 10.1016/S0169-4758(00)01774-9.View ArticlePubMedGoogle Scholar
- Casals-Pascual C, Roberts DJ: Severe malarial anaemia. Curr Mol Med. 2006, 6: 155-168. 10.2174/156652406776055159.View ArticlePubMedGoogle Scholar
- Abdalla SH: Peripheral blood and bone marrow leucocytes in Gambian children with malaria: numerical changes and evaluation of phagocytosis. Ann Trop Paediatr. 1988, 8: 250-258.PubMedGoogle Scholar
- Chang KH, Stevenson MM: Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. Int J Parasitol. 2004, 34: 1501-1516. 10.1016/j.ijpara.2004.10.008.View ArticlePubMedGoogle Scholar
- Lamikanra AA, Brown D, Potocnik A, Casals-Pascual C, Langhorne J, Roberts DJ: Malarial anemia: of mice and men. Blood. 2007, 110: 18-28. 10.1182/blood-2006-09-018069.View ArticlePubMedGoogle Scholar
- Föller M, Huber SM, Lang F: Erythrocyte programmed cell death. IUBMB Life. 2008, 60: 661-668.View ArticlePubMedGoogle Scholar
- Dockrell DH: Apoptotic cell death in the pathogenesis of infectious disease. J Infect. 2001, 42: 227-234. 10.1053/jinf.2001.0836.View ArticlePubMedGoogle Scholar
- Fadeel B, Orrenius S: Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med. 2005, 258: 479-517. 10.1111/j.1365-2796.2005.01570.x.View ArticlePubMedGoogle Scholar
- Piquet PF, Kan CD, Vesin C: Thrombocytopenia in an animal model of malaria is associated with an increased caspase-mediated death of thrombocytes. Apoptosis. 2002, 7: 91-98. 10.1023/A:1014341611412.View ArticleGoogle Scholar
- Riccio EKP, Júnior IN, Riccio LRP, Alecrim MG, Corte-Real S, Morgado M, Daniel-Ribeiro CT, Ferreira-da-Cruz MF: Malaria associated apoptosis is not significantly correlated with either parasitemia or the number of previous malaria attacks. Parasitol Res. 2003, 90: 9-18.PubMedGoogle Scholar
- Touré FS, Ouwe-Missi-Oukem-Boyer O, Bisvigou U, Moussa O, Rogier C, Pino P, Mazier D, Bisser S: Apoptosis: a potential triggering mechanism of neurological manifestation in Plasmodium falciparum malaria. Parasite Immunol. 2008, 30: 47-51.PubMedGoogle Scholar
- Salmon MG, Souza JB, Butcher GA, Playfair JHL: Premature removal of uninfected erythrocytes during malarial infection of normal and immunodeficient mice. Clin Exp Immunol. 1997, 108: 471-476. 10.1046/j.1365-2249.1997.3991297.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Helegbe GK, Huy NT, Yanagi T, Shuaibu MN, Yamazaki A, Kikuchi M, Yasunami M, Hirayama K: Rate of red blood cell destruction varies in different strains of mice infected with Plasmodium berghei-ANKA after chronic exposure. Malar J. 2009, 8: 91-10.1186/1475-2875-8-91.PubMed CentralView ArticlePubMedGoogle Scholar
- Weiss L: Mechanisms of splenic control of murine malaria: cellular reactions of the spleen in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice, and the consequences of pre-infective splenectomy. Am J Trop Med Hyg. 1989, 41: 144-160.PubMedGoogle Scholar
- Wang QW, Liu Y, Liu J, Chen G, Zheng W, Wang J, Cao Y: Plasmodium yoelii: assessment of production and role of nitric oxide during the early stages of infection in susceptible and resistant mice. Exp Parasitol. 2009, 121: 268-273. 10.1016/j.exppara.2008.11.013.View ArticlePubMedGoogle Scholar
- Labbé K, Saleh M: Cell death in the host response to infection. Cell Death Differ. 2008, 15: 1339-1349.View ArticlePubMedGoogle Scholar
- Eda S, Sherman IW: Cytoadherence of malaria-infected red blood cells involves exposure of phosphatidylserine. Cell Physiol Biochem. 2002, 12: 373-384. 10.1159/000067908.View ArticlePubMedGoogle Scholar
- Koka S, Lang C, Boini KM, Bobbala D, Huber SM, Lang F: Influence of chlorpromazine on eryptosis, parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem. 2008, 22: 261-268. 10.1159/000149804.View ArticlePubMedGoogle Scholar
- Lang F, Lang PA, Lang KS, Brand V, Tanneur V, Duranton C, Wieder T, Huber SM: Channel-induced apoptosis of infected host cells-the case of malaria. Pflugers Arch. 2004, 448: 319-324. 10.1007/s00424-004-1254-9.View ArticlePubMedGoogle Scholar
- Bevers EM, Williamson PL: Phospholipid scramblase: An update. FEBS Lett. 2010, 584: 2724-2730. 10.1016/j.febslet.2010.03.020.View ArticlePubMedGoogle Scholar
- Fadok VA: Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest. 2001, 108: 957-962.PubMed CentralView ArticlePubMedGoogle Scholar
- Lang PA, Kasinathan RS, Brand VB, Duranton C, Lang C, Koka S, Shumilina E, Kempe DS, Tanneur V, Akel A, Lang KS, Foller M, Kun JF, Kremsner PG, Wesselborg S, Laufer S, Clemen CS, Herr C, Noegel AA, Wieder T, Gulbins E, Lang F, Huber SM: Accelerated clearance of Plasmodium-infected erythrocytes in sickle cell trait and annexin-A7 deficiency. Cell Physiol Biochem. 2009, 24: 415-428. 10.1159/000257529.View ArticlePubMedGoogle Scholar
- Looareesuwan S, Davis TME, Pukrittayakamee S, Supanaranond W, Desakorn V, Silamut K, Krishna S, Boonamrung S, White NJ: Erythrocyte survival in severe falciparum malaria. Acta Trop. 1991, 48: 263-270. 10.1016/0001-706X(91)90014-B.View ArticlePubMedGoogle Scholar
- Jakeman GN, Saul A, Hogarth WL, Collins WE: Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes. Parasitology. 1999, 119: 127-133. 10.1017/S0031182099004564.View ArticlePubMedGoogle Scholar
- Chilongola J, Balthazary S, Mpina M, Mhando M, Mbugi E: CD36 deficiency protects against malarial anaemia in children by reducing Plasmodium falciparum-infected red blood cell adherence to vascular endothelium. Trop Med Int Health. 2009, 14: 810-816. 10.1111/j.1365-3156.2009.02298.x.View ArticlePubMedGoogle Scholar
- Waitumbi JN, Opollo MO, Muga RO, Misore AO, Stoute JA: Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia. Blood. 2000, 95: 1481-1486.PubMedGoogle Scholar
- Keller CC, Kremsner PG, Hittner JB, Misukonis MA, Weinberg JB, Perkins DJ: Elevated nitric oxide production in children with malaria anemia: hemozoin-induced nitric oxide synthase type 2 transcription and nitric oxide in blood mononuclear cells. Infect Immun. 2004, 72: 4868-4873. 10.1128/IAI.72.8.4868-4873.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Wilson NO, Huang MB, Anderson W, Bond V, Powell M, Thompson WE, Armah HB, Adjei AA, Gyasi R, Tettey Y, Stiles JK: Soluble factors from Plasmodium falciparum-infected erythrocytes induce apoptosis in human brain vascular endothelial and neuroglia cells. Mol Biochem Parasitol. 2008, 162: 172-176. 10.1016/j.molbiopara.2008.09.003.PubMed CentralView ArticlePubMedGoogle Scholar
- Pattanapanyasat K, Sratongno P, Chimma P, Chitjamnongchai S, Polsrila K, Chotivanich K: Febrile temperature but not proinflammatory cytokines promotes phosphatidylserine expression on Plasmodium falciparum malaria-infected red blood cells during parasite maturation. Cytometry A. 2010, 77: 515-523.View ArticlePubMedGoogle Scholar
- Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B, Risler T, Wieder T, Lang F: Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol. 2003, 14: 2750-2757. 10.1097/01.ASN.0000093253.42641.C1.View ArticlePubMedGoogle Scholar
- Vedovato M, De Paoli Vitali E, Dapporto M, Salvatorelli G: Defective erythropoietin production in the anaemia of malaria. Nephrol Dial Transplant. 1999, 14: 1043-1044. 10.1093/ndt/14.4.1043.View ArticlePubMedGoogle Scholar
- Butthep P, Wanram S, Pattanapanyasat K, Vattanaviboon P, Fucharoen S, Wilairat P: Cytoadherence between endothelial cells and P. falciparum infected and noninfected normal and thalassemic red blood cells. Cytometry B Clin Cytom. 2006, 70: 432-442.View ArticlePubMedGoogle Scholar
- Setty BNY, Betal SG: Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes. Blood. 2008, 111: 905-914. 10.1182/blood-2007-07-099465.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.